Browse Category

LSE:SN News 10 January 2026 - 25 January 2026

Smith & Nephew share price slips on Friday as exec share buys surface ahead of March results

Smith & Nephew share price slips on Friday as exec share buys surface ahead of March results

London, Jan 25, 2026, 09:33 GMT — Market closed Smith & Nephew (SN.L) shares fell 0.8% on Friday, closing at 1,225.5 pence. The FTSE 100 medical-device firm’s market cap now stands near £10.4 billion. (Hargreaves Lansdown) Monday’s open looks quiet on the surface, but it’s anything but. Investors will be digesting a director-deal disclosure, assessing a new sports-medicine acquisition, and…
Smith & Nephew stock slips into the weekend — what investors are watching next week

Smith & Nephew stock slips into the weekend — what investors are watching next week

London, January 10, 2026, 09:19 GMT — Market closed Smith & Nephew shares slipped on Friday as investors turn their attention to the company’s remarks at the J.P. Morgan Healthcare Conference this week. The healthcare conference in San Francisco is already shaping up as a key barometer for sector mood and merger talk this year, with bankers and executives assembling…

Stock Market Today

  • BillionToOne (BLLN) Shares Pull Back Amid Growth Prospects and Valuation Debate
    January 25, 2026, 7:59 AM EST. BillionToOne (BLLN) shares slipped 3.3% in one day, trading near $87.57, down 1.93% year-to-date. The diagnostics company shows 22.88% annual revenue growth but trades at a 45.31% discount to a $135.29 fair value estimate. Growth in noninvasive prenatal testing and a key Johnson & Johnson diagnostic partnership support optimism. However, increased competition in prenatal testing and potential reimbursement cuts pose risks. Investors are weighing whether the sell-off highlights a buying opportunity or reflects market caution about future growth. The firm's valuation rests on assumptions of revenue expansion, margin improvement, and evolving earnings.
Go toTop